Global Drug Discovery Technologies Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 158092
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 122
  • list Pharmaceuticals and Healthcare

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. This report studies the Drug Discovery Technologies market.

Scope of the Report:

This report studies the Drug Discovery Technologies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drug Discovery Technologies market by product type and applications/end industries.

Currently, North America is the most lucrative market due to high concentration of world’s leading pharmaceutical companies. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America also gains from high-income population, collectively promising healthy potential returns on investments due to high adoption rate of new technologies. Asia Pacific holds immense promise as a market for drug discovery technologies due to rising disposable incomes, favorable long-term government policies, and aggressive investment by pharmaceutical industry in the region, which has skilled labor at affordable cost.

The global Drug Discovery Technologies market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drug Discovery Technologies.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Agilent Technologies, Inc

Abbott Laboratories, Inc.

GE Healthcare Ltd.

Albany Molecular Research Inc.

Affymetrix Inc.

Arqule Inc.

Luminex Corporation

Bayer Healthcare AG

Novartis AG

Astrazeneca plc

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Biochips

High Throughput Screening

Pharmacogenomics

Genomics

Bioanalytical Instruments

Bioinformatics

Nanotechnology

Others (RNAi, combinatorial chemistry)

Market Segment by Applications, can be divided into

Biopharmaceutical Companies

Pharmaceutical Companies

Research Institutes

Biotech Companies

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Drug Discovery Technologies Market Overview

1.1 Product Overview and Scope of Drug Discovery Technologies

1.2 Classification of Drug Discovery Technologies by Types

1.2.1 Global Drug Discovery Technologies Revenue Comparison by Types (2017-2023)

1.2.2 Global Drug Discovery Technologies Revenue Market Share by Types in 2017

1.2.3 Biochips

1.2.4 High Throughput Screening

1.2.5 Pharmacogenomics

1.2.6 Genomics

1.2.7 Bioanalytical Instruments

1.2.8 Bioinformatics

1.2.9 Nanotechnology

1.2.10 Others (RNAi, combinatorial chemistry)

1.3 Global Drug Discovery Technologies Market by Application

1.3.1 Global Drug Discovery Technologies Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Biopharmaceutical Companies

1.3.3 Pharmaceutical Companies

1.3.4 Research Institutes

1.3.5 Biotech Companies

1.4 Global Drug Discovery Technologies Market by Regions

1.4.1 Global Drug Discovery Technologies Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Drug Discovery Technologies Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Drug Discovery Technologies Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Discovery Technologies Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Drug Discovery Technologies Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Discovery Technologies Status and Prospect (2013-2023)

1.5 Global Market Size of Drug Discovery Technologies (2013-2023)

2 Manufacturers Profiles

2.1 Agilent Technologies, Inc

2.1.1 Business Overview

2.1.2 Drug Discovery Technologies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Agilent Technologies, Inc Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott Laboratories, Inc.

2.2.1 Business Overview

2.2.2 Drug Discovery Technologies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Laboratories, Inc. Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.3 GE Healthcare Ltd.

2.3.1 Business Overview

2.3.2 Drug Discovery Technologies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GE Healthcare Ltd. Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.4 Albany Molecular Research Inc.

2.4.1 Business Overview

2.4.2 Drug Discovery Technologies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Albany Molecular Research Inc. Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.5 Affymetrix Inc.

2.5.1 Business Overview

2.5.2 Drug Discovery Technologies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Affymetrix Inc. Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.6 Arqule Inc.

2.6.1 Business Overview

2.6.2 Drug Discovery Technologies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Arqule Inc. Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.7 Luminex Corporation

2.7.1 Business Overview

2.7.2 Drug Discovery Technologies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Luminex Corporation Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.8 Bayer Healthcare AG

2.8.1 Business Overview

2.8.2 Drug Discovery Technologies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Bayer Healthcare AG Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.9 Novartis AG

2.9.1 Business Overview

2.9.2 Drug Discovery Technologies Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis AG Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

2.10 Astrazeneca plc

2.10.1 Business Overview

2.10.2 Drug Discovery Technologies Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Astrazeneca plc Drug Discovery Technologies Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drug Discovery Technologies Market Competition, by Players

3.1 Global Drug Discovery Technologies Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Drug Discovery Technologies Players Market Share

3.2.2 Top 10 Drug Discovery Technologies Players Market Share

3.3 Market Competition Trend

4 Global Drug Discovery Technologies Market Size by Regions

4.1 Global Drug Discovery Technologies Revenue and Market Share by Regions

4.2 North America Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

4.3 Europe Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

4.5 South America Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

5 North America Drug Discovery Technologies Revenue by Countries

5.1 North America Drug Discovery Technologies Revenue by Countries (2013-2018)

5.2 USA Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

5.3 Canada Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

5.4 Mexico Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

6 Europe Drug Discovery Technologies Revenue by Countries

6.1 Europe Drug Discovery Technologies Revenue by Countries (2013-2018)

6.2 Germany Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

6.3 UK Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

6.4 France Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

6.5 Russia Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

6.6 Italy Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Drug Discovery Technologies Revenue by Countries

7.1 Asia-Pacific Drug Discovery Technologies Revenue by Countries (2013-2018)

7.2 China Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

7.3 Japan Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

7.4 Korea Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

7.5 India Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

8 South America Drug Discovery Technologies Revenue by Countries

8.1 South America Drug Discovery Technologies Revenue by Countries (2013-2018)

8.2 Brazil Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

8.3 Argentina Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

8.4 Colombia Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Drug Discovery Technologies by Countries

9.1 Middle East and Africa Drug Discovery Technologies Revenue by Countries (2013-2018)

9.2 Saudi Arabia Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

9.3 UAE Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

9.4 Egypt Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

9.5 Nigeria Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

9.6 South Africa Drug Discovery Technologies Revenue and Growth Rate (2013-2018)

10 Global Drug Discovery Technologies Market Segment by Type

10.1 Global Drug Discovery Technologies Revenue and Market Share by Type (2013-2018)

10.2 Global Drug Discovery Technologies Market Forecast by Type (2018-2023)

10.3 Biochips Revenue Growth Rate (2013-2023)

10.4 High Throughput Screening Revenue Growth Rate (2013-2023)

10.5 Pharmacogenomics Revenue Growth Rate (2013-2023)

10.6 Genomics Revenue Growth Rate (2013-2023)

10.7 Bioanalytical Instruments Revenue Growth Rate (2013-2023)

10.8 Bioinformatics Revenue Growth Rate (2013-2023)

10.9 Nanotechnology Revenue Growth Rate (2013-2023)

10.10 Others (RNAi, combinatorial chemistry) Revenue Growth Rate (2013-2023)

11 Global Drug Discovery Technologies Market Segment by Application

11.1 Global Drug Discovery Technologies Revenue Market Share by Application (2013-2018)

11.2 Drug Discovery Technologies Market Forecast by Application (2018-2023)

11.3 Biopharmaceutical Companies Revenue Growth (2013-2018)

11.4 Pharmaceutical Companies Revenue Growth (2013-2018)

11.5 Research Institutes Revenue Growth (2013-2018)

11.6 Biotech Companies Revenue Growth (2013-2018)

12 Global Drug Discovery Technologies Market Size Forecast (2018-2023)

12.1 Global Drug Discovery Technologies Market Size Forecast (2018-2023)

12.2 Global Drug Discovery Technologies Market Forecast by Regions (2018-2023)

12.3 North America Drug Discovery Technologies Revenue Market Forecast (2018-2023)

12.4 Europe Drug Discovery Technologies Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Drug Discovery Technologies Revenue Market Forecast (2018-2023)

12.6 South America Drug Discovery Technologies Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Drug Discovery Technologies Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Drug Discovery Technologies Picture

Table Product Specifications of Drug Discovery Technologies

Table Global Drug Discovery Technologies and Revenue (Million USD) Ma

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery